Literature DB >> 2417479

Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor.

F Graus, K B Elkon, C Cordon-Cardo, J B Posner.   

Abstract

An autoantibody highly restricted to the nuclei of neurons was found in four patients with subacute sensory neuronopathy and small cell carcinoma of the lung. The antibody was not found in normal subjects or patients with or without cancer who did not have subacute sensory neuronopathy. One- and two-dimensional immunoblotting analysis of nuclear extracts of rat and human brain identified an antibody reactive with a 35-38 kilodalton (kd) basic nucleoprotein. An identical protein lacking the 38 kd peptide was identified in tumor extract of one of the patients. All four patients' serum reacted with the same antigen in the brain and the tumor. In the postmortem study of one of the patients, IgG was found within the neurons of the dorsal root ganglia by direct immunofluorescence. These findings support the hypothesis that the subacute sensory neuronopathy is caused by an antibody that cross-reacts with a tumor cell antigen and a brain nucleoprotein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417479     DOI: 10.1016/0002-9343(86)90047-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  46 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Antineuronal antibodies in small cell lung carcinoma--a significance for paraneoplastic syndromes?

Authors:  W Grisold; M Drlicek; W Popp; K Jellinger
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Purkinje cell antibodies in a patient with cerebellar disorder.

Authors:  F Graus
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

Review 4.  Neuroendocrine differentiation in lung tumours.

Authors:  M N Sheppard
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

5.  Large and small fibre type sensory dysfunction in patients with cancer.

Authors:  R B Lipton; B S Galer; J P Dutcher; R K Portenoy; V Pahmer; F Meller; J C Arezzo; P H Wiernik
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

6.  Paraneoplastic limbic encephalitis: clinico-pathological correlations.

Authors:  A M Bakheit; P G Kennedy; P O Behan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

7.  Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjögren's syndrome.

Authors:  J A Molina; J Benito-León; F Bermejo; F J Jiménez-Jiménez; J Oliván
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

8.  Sera from some patients with antibody-associated paraneoplastic encephalomyelitis/sensory neuronopathy recognize the Ro-52K antigen.

Authors:  G Manley; E Wong; J Dalmau; K Elkon; J Posner; H Furneaux
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 9.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

Authors:  R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Immune response in lung cancer mouse model mimics human anti-Hu reactivity.

Authors:  Meleeneh Kazarian; Joaquim Calbo; Natalie Proost; Catherine L Carpenter; Anton Berns; Ite A Laird-Offringa
Journal:  J Neuroimmunol       Date:  2009-09-17       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.